Business
Press Release Jul 25 2023
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated July 25, 2023, titled "Eugia Pharma receives USFDA Approval for Plerixafor Injection, 24 mg/1.2 mL (20 mg/mL), Single-Dose Vial".
About this update from Aurobindo Pharma Ltd
[{"type":"text","content":" Aurobindo Pharma Limited has informed the Exchange regarding a press release dated July 25, 2023, titled \"Eugia Pharma receives USFDA Approval for Plerixafor Injection, 24 mg/1.2 mL (20 mg/mL), Single-Dose Vial\". View Attachment","length":383,"tagName":"div"}]